AUG Therapeutics
Quick facts
Phase 3 pipeline
- AVTX-803
- AVTX-803 (L-Fucose) · Oncology
L-Fucose is a simple sugar that enhances the fucosylation of antibodies and immune cells to improve their effector functions and anti-tumor activity.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: